Inobrodib: A New Oral Myeloma Treatment with Dr. Nisha Joseph image

Inobrodib: A New Oral Myeloma Treatment with Dr. Nisha Joseph

Posted on: Aug 28, 2026
Play Episode
Also available on
Description

A new oral myeloma treatment is now in development. It doesn't work like anything else in your treatment history and has activity in patients who've run out of options. Join us as Dr. Nisha Joseph of Emory's Winship Cancer Institute breaks down how Inobrodib works, who it might help, and where it fits in the future of myeloma care.

Thank you to our sponsor for this episode

User uploaded media
On this episode
Healthtree contact Jenny Ahlstrom

Jenny Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Healthtree contact Nisha Joseph, MD

Nisha Joseph, MD

Nisha Joseph, MD is Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in hematology and medical oncology, she specializes in treating patients with plasma cell disorders including multiple myeloma and amyloidosis. She is also an active clinical researcher in the fields of multiple myeloma, amyloidosis and bone marrow transplant. Dr. Joseph is a member of the Clinical and Translational Review Committee and the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute, and serves as the director of the Morbidity and Mortality conferences of the Department of Hematology and Oncology. She co-leads the Winship Summer Scholars Program, providing high school students with a unique immersion experience in a cancer research laboratory. Dr. Joseph was named the first H. Jean Khoury Fellow in Leukemia and Bone Marrow Transplant prior to joining the faculty at Winship Cancer Institute. Dr. Joseph holds professional memberships with American Society of Clinical Oncology and American Society of Hematology.

Related Content